NEW GAMMA INNOVATION Trademark

Trademark Overview


On Thursday, September 30, 2021, a trademark application was filed for NEW GAMMA INNOVATION with the United States Patent and Trademark Office. The USPTO has given the NEW GAMMA INNOVATION trademark a serial number of 97053710. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, January 23, 2023. This trademark is owned by New Beta Innovation Limited. The NEW GAMMA INNOVATION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biological research; chemical research; clinical trials; medical research; scientific research; biotechnology research; biotechnology testing; conducting clinical trials; conducting clinical trials for pharmaceutical products; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; laboratory research services relating to pharmaceuticals; medical research laboratory services; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research of pharmaceuticals; research on the subject of pharmaceuticals; services for assessing the efficiency of pharmaceuticals; testing of pharmaceuticals; des...
new gamma innovation

General Information


Serial Number97053710
Word MarkNEW GAMMA INNOVATION
Filing DateThursday, September 30, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, January 23, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBiological research; chemical research; clinical trials; medical research; scientific research; biotechnology research; biotechnology testing; conducting clinical trials; conducting clinical trials for pharmaceutical products; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; laboratory research services relating to pharmaceuticals; medical research laboratory services; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research of pharmaceuticals; research on the subject of pharmaceuticals; services for assessing the efficiency of pharmaceuticals; testing of pharmaceuticals; design and development of medical diagnostic apparatus

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 28, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNew Beta Innovation Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHong Kong
HK

Trademark Events


Event DateEvent Description
Monday, January 23, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, January 23, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, January 23, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, July 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 7, 2022NON-FINAL ACTION E-MAILED
Thursday, July 7, 2022NON-FINAL ACTION WRITTEN
Thursday, June 30, 2022ASSIGNED TO EXAMINER
Thursday, October 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 4, 2021NEW APPLICATION ENTERED